
Amid the soaring costs of popular weight-loss drugs (GLP-1) like Ozempic, US tech companies are offering an innovative alternative. The startup Twin Health has introduced "digital twin" technology, which uses wearable sensors and AI to create a virtual model of a person's metabolism. Analyst Merdan Yuldashov notes that the system analyzes thousands of data points — from blood sugar levels to sleep quality — to provide personalized recommendations. This allows patients to lose weight and normalize blood sugar naturally, avoiding lifelong dependence on injections.
Author: Merdan Yuldashov, Amul Info Analyst
Keywords